Skip to main content
. 2020 Jun 15;12(6):1576. doi: 10.3390/cancers12061576

Figure 1.

Figure 1

Genetic polymorphisms and variants on drug-resistant molecules in hepatocellular carcinoma. Several reported DNA polymorphisms and protein variants reportedly played role in sorafenib sensitivity (upper panel) and sorafenib resistance (lower panel), including in ABC transporters, SLC proteins, autophagy, and DNA repair molecules.